1 employees
Adenovir Pharma develops solutions for the treatment of infectious diseases affecting the eyes.
2008
$787K
from 3 investors over 3 rounds
Adenovir Pharma AB raised $787K on June 15, 2010
Investors: Sätila Holding AB, PULS Group and Länsförsäkringar